BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27864924)

  • 1. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
    Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L
    Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study.
    Vecchié A; Bonaventura A; Meessen J; Novelli D; Minetti S; Elia E; Ferrara D; Ansaldo AM; Scaravilli V; Villa S; Ferla L; Caironi P; Latini R; Carbone F; Montecucco F;
    J Intern Med; 2021 Feb; 289(2):179-192. PubMed ID: 32686253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients.
    Vassalli F; Masson S; Meessen J; Pasticci I; Bonifazi M; Vivona L; Caironi P; Busana M; Giosa L; Macrì MM; Romitti F; Novelli D; Quintel M; Latini R; Gattinoni L
    Shock; 2020 Nov; 54(5):675-680. PubMed ID: 32941388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
    Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
    Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
    Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Maggio G; Cavana M; Tognoni G; Pesenti A; Gattinoni L; Masson S;
    Chest; 2017 Aug; 152(2):312-320. PubMed ID: 28411114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
    Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
    Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
    Muller B; Peri G; Doni A; Torri V; Landmann R; Bottazzi B; Mantovani A
    Crit Care Med; 2001 Jul; 29(7):1404-7. PubMed ID: 11445697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of resistin and myeloperoxidase in severe sepsis and septic shock: Results from the ALBIOS trial.
    Bonaventura A; Carbone F; Vecchié A; Meessen J; Ferraris S; Beck E; Keim R; Minetti S; Elia E; Ferrara D; Ansaldo AM; Novelli D; Caironi P; Latini R; Montecucco F
    Eur J Clin Invest; 2020 Oct; 50(10):e13333. PubMed ID: 32585739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Source of Circulating Pentraxin 3 in Septic Shock Patients.
    Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
    Front Immunol; 2018; 9():3048. PubMed ID: 30687307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
    Røsjø H; Masson S; Caironi P; Stridsberg M; Magnoli M; Christensen G; Moise G; Urbano MC; Gattinoni L; Pesenti A; Latini R; Omland T;
    Crit Care Med; 2018 May; 46(5):e404-e410. PubMed ID: 29481425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.
    Bastrup-Birk S; Skjoedt MO; Munthe-Fog L; Strom JJ; Ma YJ; Garred P
    PLoS One; 2013; 8(9):e73119. PubMed ID: 24039869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock.
    Tian R; Wang X; Pan T; Li R; Wang J; Liu Z; Chen E; Mao E; Tan R; Chen Y; Liu J; Qu H
    Scand J Immunol; 2019 Dec; 90(6):e12823. PubMed ID: 31489646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions.
    Song J; Park DW; Moon S; Cho HJ; Park JH; Seok H; Choi WS
    BMC Infect Dis; 2019 Nov; 19(1):968. PubMed ID: 31718563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma pentraxin 3 levels in patients with septic shock admitted to intensive care.
    Perez-San Martin S; Suberviola B; Garcia-Unzueta MT; Lavin BA; Campos S; Santibañez M
    PLoS One; 2020; 15(12):e0243849. PubMed ID: 33301518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis.
    Wagenaar JF; Goris MG; Gasem MH; Isbandrio B; Moalli F; Mantovani A; Boer KR; Hartskeerl RA; Garlanda C; van Gorp EC
    J Infect; 2009 Jun; 58(6):425-32. PubMed ID: 19443038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Septic shock-3 vs 2: an analysis of the ALBIOS study.
    Vasques F; Duscio E; Romitti F; Pasticci I; Caironi P; Meessen J; Latini R; Cressoni M; Camporota L; Pesenti A; Fumagalli R; Quintel M; Gattinoni L
    Crit Care; 2018 Sep; 22(1):237. PubMed ID: 30261898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3, a Predicator for 28-Day Mortality in Patients With Septic Shock.
    Jie H; Li Y; Pu X; Ye J
    Am J Med Sci; 2017 Mar; 353(3):242-246. PubMed ID: 28262210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin replacement in patients with severe sepsis or septic shock.
    Caironi P; Tognoni G; Masson S; Fumagalli R; Pesenti A; Romero M; Fanizza C; Caspani L; Faenza S; Grasselli G; Iapichino G; Antonelli M; Parrini V; Fiore G; Latini R; Gattinoni L;
    N Engl J Med; 2014 Apr; 370(15):1412-21. PubMed ID: 24635772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.